A gut-lung connection influences susceptibility to infection by Acinetobacter baumannii, a leading cause of hospital-acquired ...
Sulbactam-durlobactam is the first pathogen-targeted therapy under investigation for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results